Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
Updated TGA recommendations broaden therapist eligibility, accept a wider range of treatment settings, and reinforce Australia’s position as the world’s leading commercial market for prescribed psilocybin and MDMA VANCOUVER, British Columbia, May 29, 2026 (GLOBE NEWSWIRE) — via IBN – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the “Company” or “Optimi“), a commercial-stage […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.